NMI 826Alternative Names: NO-enhanced lansoprazole
Latest Information Update: 21 Nov 2006
At a glance
- Originator NitroMed
- Mechanism of Action Proton pump inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Gastric ulcer
Most Recent Events
- 21 Nov 2006 Discontinued - Preclinical for Gastric ulcer in USA (unspecified route)
- 09 Aug 2000 New profile
- 09 Aug 2000 Preclinical development for Gastric ulcer in USA (Unknown route)